Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Repeat Ivermectin Mass Drug Administrations for Malaria Control II: Protocol for a Double-blind, Cluster-Randomized, Placebo-Controlled Trial for the Integrated Control of Malaria.
Foy BD, Some A, Magalhaes T, Gray L, Rao S, Sougue E, Jackson CL, Kittelson J, Slater HC, Bousema T, Da O, Coulidiaty AGV, Colt M, Wade M, Richards K, Some AF, Dabire RK, Parikh S. Foy BD, et al. JMIR Res Protoc. 2023 Mar 20;12:e41197. doi: 10.2196/41197. JMIR Res Protoc. 2023. PMID: 36939832 Free PMC article.
Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial.
Foy BD, Alout H, Seaman JA, Rao S, Magalhaes T, Wade M, Parikh S, Soma DD, Sagna AB, Fournet F, Slater HC, Bougma R, Drabo F, Diabaté A, Coulidiaty AGV, Rouamba N, Dabiré RK. Foy BD, et al. Lancet. 2019 Apr 13;393(10180):1517-1526. doi: 10.1016/S0140-6736(18)32321-3. Epub 2019 Mar 14. Lancet. 2019. PMID: 30878222 Free PMC article. Clinical Trial.
Design and analysis of a 2-year parallel follow-up of repeated ivermectin mass drug administrations for control of malaria: Small sample considerations for cluster-randomized trials with count data.
Jackson CL, Colborn K, Gao D, Rao S, Slater HC, Parikh S, Foy BD, Kittelson J. Jackson CL, et al. Among authors: foy bd. Clin Trials. 2021 Oct;18(5):582-593. doi: 10.1177/17407745211028581. Epub 2021 Jul 3. Clin Trials. 2021. PMID: 34218684 Free PMC article.
Analysis of the RIMDAMAL trial - Authors' reply.
Foy BD, Rao S, Parikh S, Slater HC, Dabiré RK. Foy BD, et al. Lancet. 2019 Sep 21;394(10203):1006-1007. doi: 10.1016/S0140-6736(19)32139-7. Lancet. 2019. PMID: 31544742 No abstract available.
Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study.
Slater HC, Foy BD, Kobylinski K, Chaccour C, Watson OJ, Hellewell J, Aljayyoussi G, Bousema T, Burrows J, D'Alessandro U, Alout H, Ter Kuile FO, Walker PGT, Ghani AC, Smit MR. Slater HC, et al. Among authors: foy bd. Lancet Infect Dis. 2020 Apr;20(4):498-508. doi: 10.1016/S1473-3099(19)30633-4. Epub 2020 Jan 13. Lancet Infect Dis. 2020. PMID: 31948767 Free article.
112 results